Related Experiment Video
Updated: Feb 28, 2026

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
Infants exposed to maternal type 1 diabetes: intrauterine epigenetic modifications and neurological development
Nieves Luisa González-González1, Enrique González-Dávila2, José Ramón Castro-Conde1,3
1Obstetrics and Gynecology Department, Facultad de Ciencias de la Salud, Sección de Medicina. University of La Laguna (ULL), San Cristóbal de La Laguna, Tenerife, Spain.
Insights
Maternal Type-1 diabetes is linked to infant neurodevelopmental changes via fetal DNA methylation. This pilot study found specific gene methylation differences associated with lower cognitive, language, and motor scores in exposed infants.
Area of Science:
- Epigenetics
- Developmental Neuroscience
- Maternal Health
Background:
- The impact of maternal Type-1 diabetes on infant neurodevelopment and its connection to fetal DNA methylation remains unexplored.
- Investigating intrauterine epigenetic modifications in infants exposed to maternal diabetes is crucial for understanding neurodevelopmental outcomes.
Purpose of the Study:
- To determine if neurodevelopmental outcomes in offspring of mothers with Type-1 diabetes are associated with intrauterine epigenetic changes in fetal DNA.
- To explore the relationship between maternal diabetes, fetal DNA methylation, and infant neurodevelopment.
Main Methods:
- A prospective, pilot case-control study comparing infants exposed to maternal Type-1 diabetes with control infants.
- Analysis of cord blood DNA methylation using the TruSeq-Methyl-Capture-EPIC-Kit, covering over 3.3 million CpGs.
- Assessment of infant neurodevelopment using the Bayley-III Scales and correlation with DNA methylation data.
Main Results:
- Identified 108 differentially methylated genes in infants exposed to maternal diabetes, enriched in neurodevelopmental pathways like learning, synapse organization, and neurogenesis.
- Significant methylation differences observed in key neurological genes including MYT1L, NRXN1, SHANK3, and KIRREL3.
- Infants exposed to maternal diabetes showed lower Bayley-III scores in cognitive, language, and motor domains; specific gene methylation correlated with these scores.
Conclusions:
- This study provides initial evidence supporting the hypothesis that neurodevelopmental alterations in offspring of mothers with Type-1 diabetes are linked to intrauterine DNA methylation changes.
- These epigenetic changes, identifiable at birth, may contribute to observed neurodevelopmental differences.
- Further research is needed to confirm these findings and elucidate the mechanisms involved.
Background:
The relationship between the neurodevelopment in infants exposed to maternal Type-1 diabetes and changes in fetal DNA methylation has not yet been investigated.
Aim:
This hypothesis-generating study, we aimed to determine whether neurodevelopmental outcomes in offspring from mothers with Type-1 diabetes are associated with intrauterine epigenetic changes in fetal DNA.
Material And Methods:
We conducted a prospective, pilot case-control study, comparing infants exposed to maternal Type-1-diabetes with control infants. Cord blood DNA samples were analyzed using the TruSeq-Methyl-Capture-EPIC-Kit, covering over 3.3 million CpGs. The Bayley-III Scales were used to assess infant neurodevelopment, and the scores were correlated with the newborn DNA methylation data.
Results:
In infants exposed to maternal diabetes, we identified 108 differentially methylated genes enriched in pathways crucial for neurodevelopment: Vocal, Imitative and Observational Learning, Synapse Organization, and Neurogenesis. The greatest methylation differences were observed in differentially methylated regions (DMRs) annotated to key neurological genes: MYT1L (21.61%, q=1.97E-07), NRXN1 (12.30%, q=5.04E-75), SHANK3 (11.62%, q=9.81E-06) and KIRREL3 (7.35%, q= 1.53E-23). Both, NRXN1 and SHANK3, were enriched across all identified neurodevelopmental pathways. At two years of age, the infants exposed to maternal Type-1 diabetes scored significantly lower on the Bayley-III Scales across the cognitive, language, and motor domains. Methylation values across loci annotated to ten neurodevelopment-associated genes were linked to Bayley-III cognitive, language, and/or motor domain scores-with MYT1L and NRXN1 showing significant correlation with the Bayley-III language domain score.
Conclusions:
While further confirmation is needed, we provide the first results supporting the hypothesis that neurodevelopmental alterations observed in offspring of mothers with Type-1 diabetes are potentially associated with DNA methylation changes during intrauterine life which can be identified at birth.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Teratogenicity
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Epigenetic Regulation
X-chromosome...

